Galafold
Ended Awarded
- Contract number
- 36C25925F0023
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is a $21,089.47 firm fixed price delivery order for the supply of Galafold (migalastat), an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The contract has an ultimate completion date of October 7, 2024 and was awarded on October 3, 2024. The contract is not set aside and Amicus Therapeutics US, LLC is the prime contractor without any identified subcontractors. The contract supports the VA's mission to provide specialized healthcare services and medications to veterans across the country, specifically through the Veterans Integrated Service Network (VISN) serving regions such as Philadelphia, Pennsylvania.
Quick answers
Who was awarded contract 36C25925F0023?
36C25925F0023 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 19 (Veterans Health Administration) on October 3, 2024.
How much is contract 36C25925F0023 worth?
The government has obligated $21,089 on 36C25925F0023.
Is contract 36C25925F0023 an order under another contract?
Yes. 36C25925F0023 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25925F0023 competed?
The extent of competition for 36C25925F0023 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award